Metabolic Mind

How Experts Recommend Using Ketogenic Therapy In Psychiatry (New Consensus)

Mar 2, 2026
Dr. Georgia Ede, a Harvard-trained psychiatrist focused on nutritional psychiatry and ketogenic therapy, and Dr. Matthew Bernstein, a Harvard-trained psychiatrist leading clinical integration of metabolic approaches, discuss a new expert consensus on using ketogenic metabolic therapy in serious mental illness. They cover how the consensus was developed, who may be appropriate candidates, safety and contraindications, recommended monitoring, trial length, and practical implementation tips.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Delphi Consensus Bridges Evidence Gap

  • A Delphi consensus fills the gap where RCT-level evidence is lacking by pooling expert clinical experience to guide practice.
  • The panel created 33 consensus statements and distilled them into 10 practical recommendations for clinicians treating serious mental illness.
ADVICE

Use KMT As Adjunct For Serious Mental Illness

  • Consider ketogenic metabolic therapy (KMT) as an adjunct to first-line treatments for major depressive disorder, bipolar disorder, and schizophrenia.
  • Offer KMT especially for patients who decline, don't tolerate, can't access, or haven't benefited from standard therapies.
ANECDOTE

Clinician Reflection On Earlier Adoption

  • Matt Bernstein said he would have benefited from reading these consensus recommendations six years earlier when starting KMT.
  • He believes the paper would have accelerated his clinical adoption and built confidence to expand practice sooner.
Get the Snipd Podcast app to discover more snips from this episode
Get the app